Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates
about
Lentiviral vectors in gene therapy: their current status and future potentialDevelopment of an inducible caspase-9 safety switch for pluripotent stem cell-based therapiesThymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In VitroRecent developments in doping testing for erythropoietin.Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.Recent advances in developing nucleic acid-based HBV therapy.Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase.Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.
P2860
Q24629462-CBFBA5D6-B26E-4572-A456-39BD28CB7AC7Q34044181-EA8739B4-AF28-410A-B840-32C9968C4564Q34295186-E997BF7A-F619-40F3-AC5C-727D328EA901Q35028209-87BDD2CA-035C-4918-88F4-07FF4AD8113FQ35161543-BB013C42-F7FE-48DF-963D-71EB55AE82DBQ35917970-CF7B3AFA-4D49-4618-8223-3948EF410C4EQ37884431-EFC0734F-4948-4458-9369-5117BE1E1E11Q37931159-605DB1A8-B946-40EC-ACF7-473BF6C55198Q38029405-C2BE40F0-28D2-49DE-9673-E51F0B51F910Q38160538-BE043401-38D0-4F14-9A09-16C0F4B5A3B4Q38800411-630298A3-94CD-47F1-AA4A-A983015D66D6Q40059344-750ACFF9-06C3-445F-987A-125949E998BFQ40418970-E8F2FC2D-A742-48F3-83EE-610234D2F44DQ41691498-34136CB6-DDF7-44F3-ABFD-8483911C1E50
P2860
Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@ast
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@en
type
label
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@ast
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@en
prefLabel
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@ast
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@en
P2093
P2860
P356
P1433
P1476
Biosafety in ex vivo gene ther ...... patocytes in nonhuman primates
@en
P2093
Barbara E Wildhaber
Christophe Chardot
Didier Trono
Françoise Lasne
Jacques Birraux
Olivier Menzel
Tuan H Nguyen
Walid Habre
P2860
P304
P356
10.1038/MT.2009.143
P577
2009-06-30T00:00:00Z